Catalyst Wire Dossier Catalyst Wire Dossier

Tiselizumab

Tiselizumab
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tiselizumab, covering 2024-06-24 to 2024-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma [Phase 2]

See pricing